NDC 71335-0280 – Acyclovir

Acyclovir 200 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71335-0280

Product details

Brand name
Acyclovir
Generic name
Acyclovir
Labeler
Bryant Ranch Prepack
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075090
Marketed since
May 27, 2021
Listing expires
December 31, 2026
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Acyclovir →

Package NDC codes (10)

Package NDCDescriptionSince
71335-0280-090 CAPSULE in 1 BOTTLE (71335-0280-0)Jul 21, 2021
71335-0280-130 CAPSULE in 1 BOTTLE (71335-0280-1)Dec 27, 2021
71335-0280-225 CAPSULE in 1 BOTTLE (71335-0280-2)Dec 27, 2021
71335-0280-335 CAPSULE in 1 BOTTLE (71335-0280-3)Dec 27, 2021
71335-0280-450 CAPSULE in 1 BOTTLE (71335-0280-4)Dec 27, 2021
71335-0280-5100 CAPSULE in 1 BOTTLE (71335-0280-5)Dec 27, 2021
71335-0280-640 CAPSULE in 1 BOTTLE (71335-0280-6)Dec 27, 2021
71335-0280-760 CAPSULE in 1 BOTTLE (71335-0280-7)Dec 27, 2021
71335-0280-8120 CAPSULE in 1 BOTTLE (71335-0280-8)Oct 21, 2021
71335-0280-920 CAPSULE in 1 BOTTLE (71335-0280-9)Dec 27, 2021

Other Acyclovir products